Ingram Megan, Choi Yun Hee, Chiu Chung-Yi, Haggard Rob, Dougall Angela Liegey, Buschang Peter, Gatchel Robert J
J Appl Biobehav Res. 2011 Dec 1;16(3-4):148-166. doi: 10.1111/j.1751-9861.2011.00068.x. Epub 2012 Jan 10.
Temporomandibular joint and muscle disorder (TMJMD) is one of the most prevalent types of musculoskeletal disorders. The major goal of the study was to more objectively quantify clinically meaningful relief for TMJMD treatment outcomes by using the new metric of minimal clinically important difference (MCID). Pre- to post-treatment changes on a number of self-report measures were evaluated in a cohort of 101 acute TMJMD patients. An anchor-based MCID approach was employed, with an objective chewing performance measure serving as the clinical outcome of interest. Using a Receiver Operating Curve analysis, it was found that the Physical Component Scale (PCS) of the SF-36 was the most robust self-report measure to use as the MCID in a TMJMD patient population.
颞下颌关节及肌肉紊乱症（TMJMD）是最常见的肌肉骨骼疾病类型之一。该研究的主要目标是通过使用最小临床重要差异（MCID）这一新指标，更客观地量化TMJMD治疗结果中具有临床意义的缓解情况。在一组101例急性TMJMD患者中，评估了多种自我报告测量指标从治疗前到治疗后的变化。采用了基于锚定的MCID方法，将客观咀嚼性能测量作为感兴趣的临床结果。通过受试者工作特征曲线分析发现，SF-36的身体成分量表（PCS）是在TMJMD患者群体中用作MCID的最可靠自我报告测量指标。
